Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
Equal Weight with a price target of $71, which was brought down from $80. The firm anticipated that intensifying competition within Dexcom's primary insulin-intensive segments throughout 2026 and 2027 would limit the stock's valuation multiple and hinder its performance in the near-to-medium term. On January 9, Bernstein adjusted its outlook for DexCom, increasing the price target to $86 from $84 while maintaining an Outperform rating. This update came as US healthcare stocks showed signs of recovery following a significant low point in September 2025. The firm noted that as the macroeconomic and policy uncertainties that hampered the sector throughout 2025 begin to clear, healthcare equities are well-positioned for a stronger performance in 2026. jason-briscoe-Gw_sFen8VhU-unsplash Furthermore, on January 7, RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on DexCom Inc. (NASDAQ:DXCM) while setting a price target of $85. DexCom Inc. (NASDAQ:DXCM) is a medical de
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.Business Wire
- INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ: DXCM) and Encourages Long-Term Investors to Contact the FirmPR Newswire
- 1 Growth Stock Down 19% to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 10/30/25 - Beat
DXCM
Sec Filings
- 1/12/26 - Form 8-K
- 12/22/25 - Form 8-K
- 11/17/25 - Form 4
- DXCM's page on the SEC website